Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Alex Rives describes Biohub's Virtual Biology Initiative with DOE, NIH, Google DeepMind, Isomorphic, and Meta as a coordinated push to generate cellular data. Top priorities include spatial biology and cell atlases linking molecular and imaging measurements across hundreds of billions of healthy and diseased cells.

Related Insights

Most organizations specialize in either frontier AI or frontier biology. CZI's Biohub integrates both to create a tight feedback loop. The AI models identify knowledge gaps, which in turn directs the biology team on what specific data sets to generate next. This flywheel of building bespoke data for model training accelerates discovery much faster than using pre-existing public data.

Alex Rives argues current virtual cell models fail because biology's measuring tools cannot observe the fine-grained causal structure models need. He says better architectures help, but Biohub is investing heavily in new measurement modalities and data generation because observation limits are the deeper bottleneck first.

Alex Rives says continuous molecular monitoring would be immensely valuable and likely converge with cell models eventually. Measuring more molecular parameters continuously could directly link bottom-up personal health data with top-down biological understanding of disease, though Biohub itself stays at the enabling technology layer.

The primary bottleneck for creating powerful foundation models in biology is the lack of clean, large-scale experimental data—orders of magnitude less than what's available for LLMs. This creates a major opportunity for "data foundries" that use robotic labs to generate high-quality biological data at scale.

Unlike language models trained on existing internet data, Biohub's biological models require data that doesn't exist yet. Their strategy pairs a frontier AI lab with a "frontier biology" effort to invent new imaging and measurement tools, creating proprietary data streams to fuel their models.

Early efforts like the Human Cell Atlas were criticized as mere data collection ("stamp collecting"). However, the rise of LLMs provided the key to unlock this data's value, transforming vast, unstructured biological datasets into systems that generate scientific insights and move biology from discovery to engineering.

The next frontier in preclinical research involves feeding multi-omics and spatial data from complex 3D cell models into AI algorithms. This synergy will enable a crucial shift from merely observing biological phenomena to accurately predicting therapeutic outcomes and patient responses.

Alex Rives says a complete cell model must include cells in tissue and living systems, not just isolated cultures. Biohub builds real imaging across atomic, cell-culture, and whole-organism scales, including zebrafish microscopes that track every cell and immune-cell trafficking as an embryo develops over time.

To build an AI that can reason about biology, researchers must first create a massive "dictionary" of normal cellular behavior. This involves capturing ~50 petabytes of unperturbed dynamics in organisms like zebra fish. Only after establishing this baseline of "native dynamics" can the model effectively interpret data from perturbed or diseased states.

Biohub is tackling biological complexity with a bottom-up, hierarchical approach. The strategy posits that you can't effectively model a complex system like a cell without first understanding its building blocks, the proteins. This layered approach ensures each level of simulation is grounded in a robust understanding of the level below it.